The global arbovirus testing market size was valued at USD 1.35 billion in 2025 and is expected to grow from USD 1.41 billion in 2026 to approximately USD 2.16 billion by 2035, registering a compound annual growth rate (CAGR) of 4.80% between 2026 and 2035. The market is expanding due to the growing need for early detection of viral infections and improved disease surveillance systems across healthcare institutions worldwide.

Read Also: Blood Ketone Meter Market

Arbovirus Testing Market Key Takeaways

• North America dominated the global arbovirus testing market with a 42% share in 2025.

• Asia Pacific is projected to grow at the fastest CAGR between 2026 and 2035.

• By type, the ELISA-based tests segment held the largest share of 49% in 2025.

• By type, the RT-PCR-based tests segment is expected to grow at the fastest rate during the forecast period.

• By end-use, diagnostic laboratories accounted for the largest market share in 2025.

• Research centers are expected to experience rapid growth over the forecast period.

What Drives the Arbovirus Testing Market?

The arbovirus testing industry is mainly driven by the increasing global incidence of mosquito-borne diseases such as Dengue Fever, Zika Virus Disease, and Chikungunya. Climate change has expanded the habitats of mosquito vectors, increasing disease transmission across new geographic regions.

Innovations in molecular diagnostic technologies such as Reverse Transcription Polymerase Chain Reaction (RT-PCR) and point-of-care diagnostic tools are enabling faster and more accurate disease detection.

In addition, international health programs such as the World Health Organization Global Arbovirus Initiative are strengthening global diagnostic infrastructure and disease surveillance systems, which further drives market growth.

What Drives the Arbovirus Testing Market?

The arbovirus testing industry is mainly driven by the increasing global incidence of mosquito-borne diseases such as Dengue Fever, Zika Virus Disease, and Chikungunya. Climate change has expanded the habitats of mosquito vectors, increasing disease transmission across new geographic regions.

Innovations in molecular diagnostic technologies such as Reverse Transcription Polymerase Chain Reaction (RT-PCR) and point-of-care diagnostic tools are enabling faster and more accurate disease detection.

In addition, international health programs such as the World Health Organization Global Arbovirus Initiative are strengthening global diagnostic infrastructure and disease surveillance systems, which further drives market growth.

Key Trends Influencing the Arbovirus Testing Market

Climate Change and Vector Expansion

Climate change and rising temperatures are expanding the geographical range of mosquito species such as Aedes aegypti, increasing the risk of arboviral disease transmission in new regions.

Technological Advancements in Diagnostics

Advancements in molecular diagnostic technologies, including PCR testing and improved serological assays such as Enzyme-Linked Immunosorbent Assay (ELISA), allow early and accurate detection of infections.

Rising Disease Outbreaks

Increasing global cases of dengue and Zika have created urgent demand for rapid and reliable diagnostic tests to support effective disease management and outbreak control.

Rapid Urbanization

Growing population density in tropical and subtropical regions accelerates the spread of mosquito-borne diseases, increasing the demand for diagnostic testing and surveillance systems.

Key Trends Influencing the Arbovirus Testing Market

Climate Change and Vector Expansion

Climate change and rising temperatures are expanding the geographical range of mosquito species such as Aedes aegypti, increasing the risk of arboviral disease transmission in new regions.

Technological Advancements in Diagnostics

Advancements in molecular diagnostic technologies, including PCR testing and improved serological assays such as Enzyme-Linked Immunosorbent Assay (ELISA), allow early and accurate detection of infections.

Rising Disease Outbreaks

Increasing global cases of dengue and Zika have created urgent demand for rapid and reliable diagnostic tests to support effective disease management and outbreak control.

Rapid Urbanization

Growing population density in tropical and subtropical regions accelerates the spread of mosquito-borne diseases, increasing the demand for diagnostic testing and surveillance systems.

Arbovirus Testing Market Value Chain Analysis

The arbovirus testing market includes multiple stages from research to patient support services.

Research and Development

Companies invest heavily in developing advanced diagnostic technologies including molecular diagnostics and genomic testing.

Major companies involved in R&D include:

• Abbott Laboratories

• Merck KGaA

• F. Hoffmann-La Roche Ltd

Clinical Trials and Regulatory Approval

New diagnostic technologies undergo rigorous clinical evaluation before receiving regulatory approval.

Companies involved in this stage include:

• bioMérieux

• IQVIA

• ICON plc

Distribution

Testing kits and diagnostic devices are distributed through manufacturers, wholesalers, hospitals, and online platforms.

Key distribution players include:

• Thermo Fisher Scientific

• GT Molecular

• Response Biomedical

Arbovirus Testing Market Segmentation

By Type

• ELISA-based Tests

• RT-PCR-based Tests

• Other Test Types

By End-Use

• Diagnostic Laboratories

• Hospitals

• Research Centers

• Other End-Use

By Region

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East & Africa

Get Sample PDF: https://www.precedenceresearch.com/checkout/8035